Diabetic nephropathy – A review of risk factors, progression, mechanism, and dietary management

Vijayakumar Natesan; Sung Jin Kim

doi:10.4062/biomolther.2020.204

Diabetic nephropathy – A review of risk factors, progression, mechanism, and dietary management

Vijayakumar Natesan, Sung Jin Kim

Research output: Contribution to journal › Review article › peer-review

105 Citations (Scopus)

Abstract

Type 2 diabetes mellitus (T2DM) leads to many health problems like diabetic nephropathy (DN). One of the key factors for chronic kidney disease and end-stage renal disease (ESRD) is T2DM. Extensive work is being done to delineate the pathogenesis of DN and to extend possible remedies. This review is intended to understand the nature of DN risk factors, progression, effects of glycemic levels, and stages of DN. We also explored the novel diagnostic and therapeutic approaches for DN such as gene therapy and stem cell treatments.

Original language	English
Pages (from-to)	365-372
Number of pages	8
Journal	Biomolecules and Therapeutics
Volume	29
Issue number	4
DOIs	https://doi.org/10.4062/biomolther.2020.204
Publication status	Published - 2021

Bibliographical note

Publisher Copyright:
© 2021 The Korean Society of Applied Pharmacology.

Keywords

Diabetic nephropathy
Hyperglycemia
Kidney disease
Novel drugs

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.4062/biomolther.2020.204

Cite this

@article{4c88c7222ac141cda3a043f9385d6007,

title = "Diabetic nephropathy – A review of risk factors, progression, mechanism, and dietary management",

abstract = "Type 2 diabetes mellitus (T2DM) leads to many health problems like diabetic nephropathy (DN). One of the key factors for chronic kidney disease and end-stage renal disease (ESRD) is T2DM. Extensive work is being done to delineate the pathogenesis of DN and to extend possible remedies. This review is intended to understand the nature of DN risk factors, progression, effects of glycemic levels, and stages of DN. We also explored the novel diagnostic and therapeutic approaches for DN such as gene therapy and stem cell treatments.",

keywords = "Diabetic nephropathy, Hyperglycemia, Kidney disease, Novel drugs",

author = "Vijayakumar Natesan and Kim, \{Sung Jin\}",

note = "Publisher Copyright: {\textcopyright} 2021 The Korean Society of Applied Pharmacology.",

year = "2021",

doi = "10.4062/biomolther.2020.204",

language = "English",

volume = "29",

pages = "365--372",

journal = "Biomolecules and Therapeutics",

issn = "1976-9148",

publisher = "Korean Society of Applied Pharmacology",

number = "4",

}

TY - JOUR

T1 - Diabetic nephropathy – A review of risk factors, progression, mechanism, and dietary management

AU - Natesan, Vijayakumar

AU - Kim, Sung Jin

PY - 2021

Y1 - 2021

N2 - Type 2 diabetes mellitus (T2DM) leads to many health problems like diabetic nephropathy (DN). One of the key factors for chronic kidney disease and end-stage renal disease (ESRD) is T2DM. Extensive work is being done to delineate the pathogenesis of DN and to extend possible remedies. This review is intended to understand the nature of DN risk factors, progression, effects of glycemic levels, and stages of DN. We also explored the novel diagnostic and therapeutic approaches for DN such as gene therapy and stem cell treatments.

AB - Type 2 diabetes mellitus (T2DM) leads to many health problems like diabetic nephropathy (DN). One of the key factors for chronic kidney disease and end-stage renal disease (ESRD) is T2DM. Extensive work is being done to delineate the pathogenesis of DN and to extend possible remedies. This review is intended to understand the nature of DN risk factors, progression, effects of glycemic levels, and stages of DN. We also explored the novel diagnostic and therapeutic approaches for DN such as gene therapy and stem cell treatments.

KW - Diabetic nephropathy

KW - Hyperglycemia

KW - Kidney disease

KW - Novel drugs

UR - https://www.scopus.com/pages/publications/85110155086

U2 - 10.4062/biomolther.2020.204

DO - 10.4062/biomolther.2020.204

M3 - Review article

AN - SCOPUS:85110155086

SN - 1976-9148

VL - 29

SP - 365

EP - 372

JO - Biomolecules and Therapeutics

JF - Biomolecules and Therapeutics

IS - 4

ER -

Diabetic nephropathy – A review of risk factors, progression, mechanism, and dietary management

Abstract

Bibliographical note

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this